Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.315 USD | +4.73% | +7.41% | -41.69% |
May. 22 | HC Wainwright Adjusts Price Target on ACELYRIN to $18 From $16, Maintains Buy Rating | MT |
May. 14 | Acelyrin, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ACELYRIN, INC. | Bio Therapeutic Drugs | +5.34% | +7.41% | -41.69% | -75.26% | - | 408M |
- Stock Market
- Equities
- SLRN Stock
- Charts Acelyrin, Inc.
- Relative Strength Chart